For research use only. Not for human or veterinary use. Not for diagnostic or therapeutic use.
Menu
Reconstitution calculator

Cited duration

Retatrutide study duration

The study cited for Retatrutide lasted 48 weeks. It is a study duration, not a recommended cycle, and no off period is stated. Population in the source: Adults with obesity, phase 2 trial (N Engl J Med 2023; 338 adults).[1]

Human trial

Sam, MBA · Human-researched and AI-assisted with full editorial review.

About the source: Trial duration: once weekly for 48 weeks. Study duration, not a recommended cycle; no off period. The phase 3 TRIUMPH-2 trial (PMID 42810372) has a primary timepoint at week 80.

Study duration

48 weeks[1] Human trial

Duration of the cited study. It describes the source and is not a recommended cycle; no off period is stated. Source

References

Numbered sources used on this page. Markers in the text link here.

  1. Phase 2 obesity trial (N Engl J Med 2023, doi 10.1056/NEJMoa2301972; 338 adults) pubmed.ncbi.nlm.nih.gov Human trial